AbbVie plans to release Q4 2024 results on Jan. 31. Analysts predict $14.8 billion in sales, $2.10 EPS. Immunology growth ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $212.73, a high ...

The bottom line? AbbVie's post-Humira prospects look far better than investors are giving it credit for. The dividend is rock-solid and should continue growing along with the share price over the ...

Acquisition adds potential novel oral peptide IL23R inhibitor for psoriasis as well as a peptide synthesis, screening and optimization platform to strengthen AbbVie's pipeline and R&D capabilities ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Gifting allows recipients to access the article for free. Pharmaceutical giant AbbVie has inked another collaboration deal with an emerging biotech company as it seeks ways to bulk up its drug ...

Get a refund on sales tax, or special financing, when you use the B&H Payboo Credit Card at the iconic camera and video equipment store.

The card is only available for Mary Kay consultants and earns decent rewards. But a general-purpose card will offer more ...

Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform.

Travel credit cards can help you tailor the kinds of rewards you want to earn and where you can apply them. Airline credit ...